Life Science News
Latest updates from the biotech and pharma world
Novartis wins approval to use SMA gene therapy in older patients
Novartis was the sole bidder in $12B deal to buy Avidity
#Avidity Biosciences#buy Avidity#chief executives#billion agreement#sole bidder
#ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins
#American Society#wins Late-breaking#Big pharma#Novartis spell#Late-breaking abstracts
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
#Therapeutic Innovations#Forecast Report#Featuring Lonza#Novo Nordisk#Market Therapeutic
Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters
#Novartis underline#Trump pharma#pharma tariff#Reuters Roche#tariff announcement